Log in
Enquire now
GenSight Biologics

GenSight Biologics

GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.

OverviewStructured DataIssuesContributors

Contents

gensight-biologics.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
RNA-based and RNA-targeted therapeutics
RNA-based and RNA-targeted therapeutics
Biology
Biology
Biotechnology
Biotechnology
Engineering
Engineering
Genetics
Genetics
Biomedical engineering
Biomedical engineering
Healthcare
Healthcare
...
Location
France
France
0
New York
New York
0
Paris
Paris
0
B2X
B2B
B2B
CEO
Bernard Gilly
Bernard Gilly
0
‌
Laurence Rodriguez
Founder
Jose alain sahel
Jose alain sahel
Serge Picaud
Serge Picaud
Luk Vandenberghe
Luk Vandenberghe
Bernard Gilly
Bernard Gilly
0
Pitchbook URL
pitchbook.com/profiles.../56525-68
Legal Name
GENSIGHT BIOLOGICS S.A.0
Date Incorporated
April 17, 2012
Number of Employees (Ranges)
11 – 50
Full Address
74, rue du Faubourg Saint-Antoine 75012 Paris FRANCE0
3 East 28th Street New York, NY 10016 USA0
CIK Number
1,641,6340
Place of Incorporation
France
France
0
Investors
Sofinnova Partners
Sofinnova Partners
Invus
Invus
Novartis Venture Fund
Novartis Venture Fund
Versant Ventures
Versant Ventures
Abingworth
Abingworth
Index Ventures
Index Ventures
Agoranov
Agoranov
Arix Bioscience plc
Arix Bioscience plc
Founded Date
January 1, 2013
Total Funding Amount (USD)
232,321,925
Latest Funding Round Date
July 17, 2025
Competitors
Akouos
Akouos
Stock Symbol
SIGHT0
Exchange
Euronext Paris
Euronext Paris
0
Board of Directors
‌
Peter Goodfellow
0
‌
Cédric Moreau
0
Bernard Gilly
Bernard Gilly
0
Jose alain sahel
Jose alain sahel
0
CTO
‌
Scott Jeffers
CFO
‌
Thomas Gidoin
0
Latest Funding Type
Initial public offering (IPO)
Initial public offering (IPO)
Patents Assigned (Count)
1
Country
United States
United States
0
France
France
0
Headquarters
Paris
Paris

Other attributes

Company Operating Status
Active
Contact Page URL
gensight-biologics.com/for...-us/
Latest Funding Round Amount (USD)
580,000
Previous Name
GENSIGHT BIOLOGICS0
SIC Code
2,8360
Wikidata ID
Q30268936

GenSight Biologics is is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like GenSight Biologics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.